Group 1:Dapagliflozin

3 trials

Sponsors

Tianjin Medical University Metabolic Diseases Hospital, Tianjin Metabolic Diseases Hospital, Shanghai Changzheng Hospital

Conditions

NephropathyType 2 Diabetes Mellitusdiabetes

Phase 4

Study for dapagliflozin on glomerular hyperfiltration and visceral fat redistribution in patients with newly diagnosed type 2 diabetes mellitus

Active, not recruitingChiCTR1900023470

Tianjin Metabolic Diseases HospitalType 2 Diabetes Mellitus

Start: 2019-06-27Updated: 2019-06-03

Efficacy and safety of dapagliflozin in patients with primary nephropathy treated with glucocorticoids: A pilot study

Active, not recruitingChiCTR2200058174

Shanghai Changzheng HospitalNephropathy

Start: 2022-04-10Updated: 2023-12-10

Unknown Phase

Efficacy of dapagliflozin versus liraglutide in overweight and obese patients with inadequately controlled type 2 diabetes with insulin therapy

Active, not recruitingChiCTR1800019864

Tianjin Medical University Metabolic Diseases Hospitaldiabetes

Start: 2018-12-16Updated: 2018-12-10